P

Pierrel SpA
MIL:PRL

Watchlist Manager
Pierrel SpA
MIL:PRL
Watchlist
Price: 1.745 EUR Market Closed
Market Cap: 95.9m EUR
Have any thoughts about
Pierrel SpA?
Write Note

Pierrel SpA
Investor Relations

Pierrel SpA engages in the development, manufacturing, and marketing of medical therapies for the pharmaceutical, bio-pharmaceutical, and life science industries. The company is headquartered in Capua, Caserta. The company went IPO on 2006-05-23. The firm specializes in the pharmaceutical research, development and the manufacture of medicines. The company operates through three segments. The Contract Manufacturing segment covers research and development of various types of drugs, such as Tube vials, bottles, ampoules, drops, sprays, tablets and gels. The company manufactures the drugs in the production facility in Capua, which consists of warehouses, chemical and microbiological laboratories, offices and utilities buildings. The Pharma segment is active in the development, registration and licensing of new drugs and medical devices. The Tech-driven Contract Research & Development Organization segment provides research of existing drugs for the treatment of rare diseases, among others.

Show more

Earnings Calls

No Earnings Calls Available

Management

Dr. Fulvio Citaredo
CEO, GM & Director
No Bio Available
Dr. Francesco Pepe
Chief Financial Officer
No Bio Available
Fabio Velotti
Sales & Pharma Director
No Bio Available
Mr. Bernardo Verrengia
Chief Quality Officer
No Bio Available
Dr. Vittorio Gennaro
Head of Outsourced Internal Audit & Member of Supervisory Body
No Bio Available

Contacts

Address
CASERTA
Capua
S.S. Appia 7 Bis 46/48
Contacts
+390823626111.0
www.pierrelgroup.com